WILLIAM PEACOCK to Health Care Costs
This is a "connection" page, showing publications WILLIAM PEACOCK has written about Health Care Costs.
Connection Strength
0.538
-
The Increased Clinical and Economic Burden of Hyperkalemia in Medicare Patients Admitted to Long-Term Care Settings. Adv Ther. 2023 03; 40(3):1204-1223.
Score: 0.166
-
Expert Panel Recommendations for the Identification and Management of Hyperkalemia and Role of Patiromer in Patients with Chronic Kidney Disease and Heart Failure. J Manag Care Spec Pharm. 2017 Apr; 23(4-a Suppl):S10-S19.
Score: 0.111
-
Validation of the multivariable In-hospital Mortality for PulmonAry embolism using Claims daTa (IMPACT) prediction rule within an all-payer inpatient administrative claims database. BMJ Open. 2015 Oct 28; 5(10):e009251.
Score: 0.100
-
Emergency department management of patients with acute decompensated heart failure. Heart Fail Rev. 2004 Jul; 9(3):187-93.
Score: 0.046
-
The value of sPESI for risk stratification in patients with pulmonary embolism. J Thromb Thrombolysis. 2019 Jul; 48(1):149-157.
Score: 0.032
-
Association between rivaroxaban use and length of hospital stay, treatment costs and early outcomes in patients with pulmonary embolism: a systematic review of real-world studies. Curr Med Res Opin. 2017 09; 33(9):1697-1703.
Score: 0.028
-
Overall Effectiveness of Rivaroxaban in Patients with Pulmonary Embolism. Clin Ther. 2017 Jul; 39(7):1426-1436.e2.
Score: 0.028
-
Rivaroxaban versus Heparin Bridging to Warfarin Therapy: Impact on Hospital Length of Stay and Treatment Costs for Low-Risk Patients with Pulmonary Embolism. Pharmacotherapy. 2016 10; 36(10):1109-1115.
Score: 0.027